NovaBay Pharmaceuticals Stock Price - NBY

0.885
-0.005 (-0.56%)
Upgrade to Real-Time
Regular Market
0.885
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
NovaBay Pharmaceuticals Inc New NBY AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.005 -0.56% 0.885 0.8594 0.91 0.91 0.89 12:46:01
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,164 1,094,247 $ 0.8828758 $ 966,084 4,645,894 0.20 - 4.78
Last Trade Time Type Quantity Stock Price Currency
12:46:01 100 $ 0.885 USD

NovaBay Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 25.39M 28.81M 26.91M $ 6.60M $ - -0.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
324.32k $ - 0.00% - 6.70%

more financials information »

NovaBay Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NBY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.85010.910.830.8742637895,0380.03494.11%
1 Month0.94131.320.8230.96554042,584,066-0.0563-5.98%
3 Months0.541.850.201.094,765,1910.34563.89%
6 Months0.5741.850.201.062,445,4660.31154.18%
1 Year0.2944.780.201.422,090,7440.591201.02%
3 Years2.605.000.201.40755,191-1.72-65.96%
5 Years17.3026.250.202.17506,016-16.42-94.88%

NovaBay Pharmaceuticals Description

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.


Your Recent History
AMEX
NBY
NovaBay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.